Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic Phase III Multicentre Clinical Trial to Evaluate the Safety and Effectiveness of a Single Dose of an Albendazole-Ivermectin Coformulation vs Albendazole for Preventive Chemotherapy of Soil-Transmitted Helminth Infections in School-Aged Children

NCT06282315 is registered in ClinicalTrials.gov with Insud Pharma as lead sponsor.

NCT NCT06282315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06282315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic Phase III Multicentre Clinical Trial to Evaluate the Safety and Effectiveness of a Single Dose of an Albendazole-Ivermectin Coformulation vs Albendazole for Preventive Chemotherapy of Soil-Transmitted Helminth Infections in School-Aged Children
Lead sponsor
Insud Pharma
Phase
Phase 3
Overall status
Recruiting
Start date
September 1, 2025
Completion date
February 28, 2027
Enrollment
20,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

soil-transmitted helminths